BRIEF published on 11/26/2025 at 00:51, 6 months 29 days ago CureVac Announces Results of Extraordinary General Meeting BioNTech Extraordinary General Meeting CureVac Shareholders Approval Legal Merger
PRESS RELEASE published on 11/26/2025 at 00:46, 6 months 29 days ago CureVac Announces Voting Results of Extraordinary General Meeting CureVac announces approval of BioNTech's exchange offer for outstanding shares at Extraordinary General Meeting with over 99.16% approval rate BioNTech MRNA Technology Exchange Offer CureVac EGM Voting Results
BRIEF published on 11/24/2025 at 13:15, 7 months 1 day ago CureVac Reports Q3 and Nine-Month Financial Results for 2025 Financial Performance MRNA Technology CureVac Q3 2025 Results BioNTech Merger
PRESS RELEASE published on 11/24/2025 at 13:10, 7 months 1 day ago CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates CureVac announces financial results for Q3 and first nine months of 2025, BioNTech transaction progresses, EMA clearance received for cancer therapy CVHNLC sqNSCLC Financial Results Cancer Therapy CureVac BioNTech Transaction EMA Clearance
BRIEF published on 08/15/2025 at 13:32, 10 months 10 days ago CureVac Reports Q2 and H1 2025 Financial Results; Announces Key Developments Financial Results MRNA Technology CureVac Patent Resolution BioNTech Acquisition
PRESS RELEASE published on 08/15/2025 at 13:27, 10 months 10 days ago CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates CureVac announces Q2 2025 financial results, business updates & agreement with BioNTech for transformative mRNA treatments. Strong cash position Financial Results BioNTech CureVac MRNA Q2 2025
BRIEF published on 08/08/2025 at 02:20, 10 months 17 days ago CureVac Settles Patent Dispute with Pfizer/BioNTech MRNA Technology CureVac Pfizer/BioNTech Patent Resolution Vaccine Royalties
PRESS RELEASE published on 08/08/2025 at 02:15, 10 months 17 days ago CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech CureVac resolves patent litigation with Pfizer/BioNTech related to mRNA-based COVID-19 vaccines, receiving $790 million and non-exclusive license agreements BioNTech MRNA Technology CureVac Patent Litigation Pfizer
BRIEF published on 06/24/2025 at 22:14, 1 year ago CureVac Reports Outcomes of Annual General Meeting MRNA Technology Annual Meeting Board Appointments Auditors CureVac
PRESS RELEASE published on 06/24/2025 at 22:09, 1 year ago CureVac Announces Voting Results of General Meeting CureVac announces voting results of Annual General Meeting, including new Management Board and Supervisory Board appointments. KPMG reappointed as external auditors Annual General Meeting Appointments Voting Results KPMG CureVac
Published on 06/25/2026 at 15:00, 38 minutes ago Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
Published on 06/25/2026 at 14:30, 1 hour 8 minutes ago Unusual Machines Expands Orlando Manufacturing Footprint to Support Battery Operations
Published on 06/25/2026 at 14:01, 1 hour 37 minutes ago Worksport (NASDAQ:WKSP) Regains $1 Bid Price Requirement, Announces CEO Town Hall, Highlights Multiple Recent Growth Drivers in CEO Letter
Published on 06/25/2026 at 14:00, 1 hour 38 minutes ago Horizon Aircraft's Leadership Team to Participate at Farnborough International Airshow 2026
Published on 06/25/2026 at 13:50, 1 hour 48 minutes ago CoTec Holdings Corp. Announces Annual and Special Meeting Results
Published on 06/25/2026 at 15:26, 11 minutes ago Your Family Entertainment AG launches transformation into an Agentic Media Company
Published on 06/25/2026 at 15:10, 27 minutes ago Abu Dhabi's cultural vision strikes a new note with landmark performing arts institution Dar al Funoon Abu Dhabi
Published on 06/25/2026 at 15:10, 27 minutes ago AFX Shares Up to 50% of Protocol Revenue with Traders as Cumulative Volume Approaches $1 Billion
Published on 06/25/2026 at 15:05, 32 minutes ago Alliance to End Plastic Waste Report Demonstrates Feasibility of Producing High-Quality Film from Household Flexible Plastic Waste
Published on 06/25/2026 at 15:01, 37 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/25/2026 at 07:30, 8 hours 8 minutes ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
Published on 06/24/2026 at 17:45, 21 hours 53 minutes ago Air Liquide continues its long-term growth in Kazakhstan with a key investment to support Silleno's world-scale plant
Published on 06/24/2026 at 17:40, 21 hours 58 minutes ago Report on share repurchases from 17 to 23 June 2026
